rss
Br J Ophthalmol 2008;92:332-336 doi:10.1136/bjo.2007.123042
  • Original Article
    • Clinical science

Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial

  1. K Mansouri1,2,
  2. S Orguel1,
  3. A Mermoud2,
  4. I Haefliger1,
  5. J Flammer1,
  6. E Ravinet2,
  7. T Shaarawy3
  1. 1
    University Eye Clinic Basel, Basel, Switzerland
  2. 2
    Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland
  3. 3
    Glaucoma Sector, Ophthalmology Clinic, University of Geneva, Geneva, Switzerland
  1. Dr T Shaarawy, Glaucoma Sector, Ophthalmology Clinic, University of Geneva, 22, rue Alcide Jentzer, 1211 Genève, Switzerland; tarek.shaarawy{at}hcuge.ch
  • Accepted 26 September 2007
  • Published Online First 22 January 2008

Abstract

Purpose: To compare the intraocular pressure (IOP) diurnal fluctuations of glaucoma patients treated with latanoprost 0.005% once a day with patients with controlled IOP after deep sclerectomy or trabeculectomy.

Methods: The trial included 60 prospectively recruited subjects with primary open-angle glaucoma. The medical group consisted of 20 patients with controlled IOP (<18 mm Hg) under latanoprost 0.005% monotherapy and with no history of previous intraocular surgery or argon laser trabeculoplasty; the surgical groups included 20 patients after trabeculectomy, and 20 patients after deep sclerectomy with collagen implant (DSCI). The patients in the surgical groups had a controlled IOP without any ocular hypotensive medications. All patients underwent a diurnal tension curve (08:00–17:00/three-hour intervals), followed by a water-drinking test (WDT) with the last IOP measurement taken at 21:00 hours. The between-group differences were tested for significance by means of analysis of variance (ANOVA).

Results: Baseline IOP was significantly different between the trabeculectomy group (10.1 mm Hg (3.4 SD)), the DSCI group (13.9 mm Hg (2.8)) and the latanoprost group (15.5 mm Hg (2.0); p = 0.005). The average IOP during the diurnal tension curve (10.1, 13.7, and 15.7 mm Hg, respectively, for the trabeculectomy, DSCI, and latanoprost groups) differed significantly between groups (ANOVA; p<0.0001), but the variation was comparable in the three groups (ANOVA; p = 0.13). After the WDT, elevation of IOP was significantly greater among patients treated with latanoprost (p = 0.003).

Conclusion: Trabeculectomy patients had a statistically significant lower average IOP in the diurnal tension curve compared with the other two groups. No wider variation in diurnal IOP with latanoprost compared with the surgical procedures was found. The IOP increase during the WDT was most marked in patients under latanoprost therapy.

Footnotes

  • Funding: This trial was supported by an unrestricted research grant from Pfizer AG, Switzerland.

  • Competing interests: None.

  • The article was presented in part at the International Glaucoma Symposium, Cape Town, South Africa, April 2005.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. bjo.2007.123042v1
    2. 92/3/332 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.